Mannheim, Germany

Juliane Becker

This inventor holds 1 USPTO granted patent. Top assignees: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universitat Heidelberg. Active years: 2016.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Juliane Becker in Oligonucleotide Labelling

Introduction

Juliane Becker is a prominent inventor based in Mannheim, Germany. She has made significant contributions to the field of molecular biology, particularly in the area of oligonucleotide labelling. Her innovative methods have the potential to enhance research in genetics and biochemistry.

Latest Patents

Juliane Becker holds a patent for a method titled "Multiple orthogonal labelling of oligonucleotides." This invention concerns a technique for the simultaneous labelling of RNA or DNA through the inverse Diels-Alder reaction and the copper-catalyzed click reaction. The method allows for a one-pot approach to introduce multiple labels into oligonucleotides after solid-phase synthesis, facilitating site-specific modifications.

Career Highlights

Throughout her career, Juliane Becker has worked with esteemed institutions such as Ruprecht-Karls-Universität Heidelberg and Deutsches Krebsforschungszentrum. Her work has been instrumental in advancing the understanding of oligonucleotide functionalities and their applications in various scientific fields.

Collaborations

Juliane Becker has collaborated with notable colleagues, including Ayan Samanta and Manfred Wiessler. These partnerships have contributed to her innovative research and the successful development of her patented methods.

Conclusion

Juliane Becker's contributions to the field of oligonucleotide labelling exemplify the impact of innovative research in molecular biology. Her patented methods are paving the way for advancements in genetic research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…